Silencing Primary Hyperoxaluria with Lumasiran: Two Year Follow-up of the Phase 3 ILLUMINATE-C Trial
Matthew A. Sparks (@Nephro_Sparks or @nephrosparks.bsky.social) is an associate professor of medicine at Duke University in Durham, NC. He is the director of the nephrology [...]